Surfactant and acquired lung diseases.

[1]  W. Martin,et al.  Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. , 1996, The Journal of laboratory and clinical medicine.

[2]  S. Kremlev,et al.  Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. , 1994, The American journal of physiology.

[3]  T. Schaberg,et al.  Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages. , 1994, The American journal of physiology.

[4]  S. Kremlev,et al.  Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. , 1994, The American journal of physiology.

[5]  P. Nibbering,et al.  Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-gamma. , 1994, Immunology.

[6]  H. Wiedemann,et al.  Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. , 1994, American journal of respiratory cell and molecular biology.

[7]  A. Jobe,et al.  Pulmonary surfactant therapy. , 1993, The New England journal of medicine.

[8]  A. Jobe,et al.  Surfactant and the adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[9]  H. Wiedemann,et al.  Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. , 1992, American journal of respiratory cell and molecular biology.

[10]  M. Krempf,et al.  Surfactant analysis during Pneumocystis carinii pneumonia in HIV-infected patients. , 1992, Chest.

[11]  C. R. Reed,et al.  Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. , 1991, The Journal of clinical investigation.

[12]  R. Rose,et al.  Increased recovery of surfactant protein A in AIDS-related pneumonia. , 1991, The American review of respiratory disease.

[13]  S. Hawgood,et al.  Pulmonary surfactant and its apoproteins. , 1990, The Journal of clinical investigation.

[14]  W. Seeger,et al.  Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. , 1990, The Journal of trauma.

[15]  W. Seeger,et al.  Surfactant abnormalities in patients with respiratory failure after multiple trauma. , 1989, The American review of respiratory disease.

[16]  S. Matalon,et al.  Alveolar hyperoxic injury in rabbits receiving exogenous surfactant. , 1989, Journal of applied physiology.

[17]  M. Avery,et al.  Surface properties in relation to atelectasis and hyaline membrane disease. , 1959, A.M.A. journal of diseases of children.

[18]  J A CLEMENTS,et al.  Surface Tension of Lung Extracts , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  R. E. Pattle,et al.  Properties, Function and Origin of the Alveolar Lining Layer , 1955, Nature.

[20]  K. v. Neergaard,et al.  Neue Auffassungen über einen Grundbegriff der Atemmechanik , 1929 .